Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Altimmune Inc (ALT)

Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 536,728
  • Shares Outstanding, K 70,902
  • Annual Sales, $ 430 K
  • Annual Income, $ -88,450 K
  • 60-Month Beta 0.08
  • Price/Sales 1,264.60
  • Price/Cash Flow N/A
  • Price/Book 3.66
Trade ALT with:

Options Overview Details

View History
  • Implied Volatility 95.64% ( -3.97%)
  • Historical Volatility 83.27%
  • IV Percentile 5%
  • IV Rank 5.93%
  • IV High 356.79% on 10/24/23
  • IV Low 79.18% on 10/02/23
  • Put/Call Vol Ratio 0.16
  • Today's Volume 6,282
  • Volume Avg (30-Day) 8,009
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 129,182
  • Open Int (30-Day) 112,768

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.35
  • Number of Estimates 4
  • High Estimate -0.29
  • Low Estimate -0.41
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +10.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.99 +24.04%
on 09/06/24
8.25 -9.94%
on 09/13/24
+0.94 (+14.48%)
since 08/16/24
3-Month
5.28 +40.85%
on 08/05/24
8.49 -12.49%
on 06/24/24
+1.52 (+25.72%)
since 06/18/24
52-Week
2.09 +255.50%
on 10/23/23
14.84 -49.93%
on 02/28/24
+4.72 (+174.17%)
since 09/18/23

Most Recent Stories

More News
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)

Telemedicine once seemed like it was going to revolutionize healthcare.

LLY : 904.97 (-0.13%)
PFE : 29.75 (-0.27%)
NVO : 132.06 (+0.05%)
TDOC : 9.09 (-0.22%)
AMZN : 186.43 (-0.24%)
NVDA : 113.37 (-1.92%)
SFIX : 4.14 (+0.98%)
VKTX : 64.45 (+2.40%)
ALT : 7.43 (-1.85%)
RHHBY : 39.6100 (+0.71%)
HIMS : 16.31 (+1.30%)
Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year

Altimmune is a little-known pharmaceutical company looking to disrupt the weight loss space.

NVO : 132.06 (+0.05%)
LLY : 904.97 (-0.13%)
ALT : 7.43 (-1.85%)
2 Small-Cap Stocks Under $20 With Over 220% Upside Potential

Wall Street is forecasting multibagger returns from these two small-cap biotech stocks over the next year.

LLY : 904.97 (-0.13%)
NVO : 132.06 (+0.05%)
MRK : 118.64 (+0.30%)
EYPT : 8.91 (+1.48%)
ALT : 7.43 (-1.85%)
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.

The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth.

LLY : 904.97 (-0.13%)
NVO : 132.06 (+0.05%)
VKTX : 64.45 (+2.40%)
ALT : 7.43 (-1.85%)
PFE : 29.75 (-0.27%)
RHHBY : 39.6100 (+0.71%)
Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?

At least one of the pair has a credible shot at finding a home in the market.

LLY : 904.97 (-0.13%)
ALT : 7.43 (-1.85%)
TERN : 10.21 (+6.02%)
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

Both competitors have promising lead programs, and enough cash, too.

LLY : 904.97 (-0.13%)
ALT : 7.43 (-1.85%)
VKTX : 64.45 (+2.40%)
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

While their share prices have traveled different paths recently, the similarity between the two companies is striking.

LLY : 904.97 (-0.13%)
MS : 99.30 (-0.54%)
ALT : 7.43 (-1.85%)
VKTX : 64.45 (+2.40%)
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

The market for weight loss medicines keeps getting hotter and hotter.

ALT : 7.43 (-1.85%)
NVO : 132.06 (+0.05%)
Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning, fueled by promising clinical data from its Phase 2 trials and heightened investor...

ALT : 7.43 (-1.85%)
Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning, fueled by promising clinical data from its Phase 2 trials and heightened investor...

ALT : 7.43 (-1.85%)

Business Summary

Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 8.47
2nd Resistance Point 8.17
1st Resistance Point 7.80
Last Price 7.43
1st Support Level 7.13
2nd Support Level 6.83
3rd Support Level 6.46

See More

52-Week High 14.84
Fibonacci 61.8% 9.97
Fibonacci 50% 8.47
Last Price 7.43
Fibonacci 38.2% 6.96
52-Week Low 2.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar